New York · 2025 Regular Session · Bill

S 6925: Relates to capping cost sharing for antiviral COVID-19 therapeutics

In committee Last action March 27, 2025: REFERRED TO INSURANCE

Plain-language summary

S 6925 is a bill introduced in the New York Senate on March 27, 2025. According to its official title, it concerns: Relates to capping cost sharing for antiviral COVID-19 therapeutics. Primary sponsor: Brad Hoylman-Sigal. Most recent recorded action (March 27, 2025): REFERRED TO INSURANCE.

Sponsors

Primary sponsor: Brad Hoylman-Sigal.